Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Procaps Group Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 3/6

Procaps Group şirketinin toplam hissedar öz sermayesi $38.5M ve toplam borcu $255.0M olup, bu da borç-öz sermaye oranını 663.2% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla $498.6M ve $460.1M dir. Procaps Group 'in FAVÖK'ü $48.7M faiz karşılama oranı 1.3 dur. Şirketin $17.6M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

663.2%

Borç/özkaynak oranı

US$255.01m

Borç

Faiz karşılama oranı	1.3x
Nakit	US$17.56m
Eşitlik	US$38.45m
Toplam yükümlülükler	US$460.10m
Toplam varlıklar	US$498.55m

Son finansal sağlık güncellemeleri

These 4 Measures Indicate That Procaps Group (NASDAQ:PROC) Is Using Debt Extensively

Mar 28

Recent updates

These 4 Measures Indicate That Procaps Group (NASDAQ:PROC) Is Using Debt Extensively

Mar 28

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: PROC 'nin kısa vadeli varlıkları ( $298.4M ) kısa vadeli yükümlülüklerini ( $202.9M ) aşıyor.

Uzun Vadeli Yükümlülükler: PROC şirketinin kısa vadeli varlıkları ( $298.4M ) uzun vadeli yükümlülüklerini ( $257.2M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: PROC 'nin net borç/öz sermaye oranı ( 617.5% ) yüksek olarak değerlendiriliyor.

Borcun Azaltılması: PROC şirketinin borç/öz sermaye oranının son 5 yılda azalıp azalmadığını belirlemek için yeterli veri yok.

Borç Kapsamı: PROC 'nin borcu işletme nakit akışı ( 24.7% ) tarafından iyi bir şekilde karşılanmaktadır.

Faiz Kapsamı: PROC 'in borcuna ilişkin faiz ödemeleri EBIT ( 1.3 x kapsam) tarafından iyi karşılanmıyor.

Procaps Group Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 3/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Procaps Group S.A. announced delayed 20-F filing

These 4 Measures Indicate That Procaps Group (NASDAQ:PROC) Is Using Debt Extensively

Recent updates

Procaps Group S.A. Announces Resignation of Ruben Minski as Board of Directors

Hoche Partners Raises Concerns on Shareholder Letter Issued by Procaps Group

Hoche Partners Criticizes Procaps Group's Majority Shareholder for Mismanagement and Rejection of Financial Restructuring Offer

Procaps Group S.A. Announces Board Changes

Procaps Group S.A. announced delayed 20-F filing

Procaps Group S.A. Provides Earnings Guidance for the Year Ended December 31, 2023

These 4 Measures Indicate That Procaps Group (NASDAQ:PROC) Is Using Debt Extensively

Procaps Group S.A. Announces Formation of Strategic Committee to Explore Value Creation Alternatives

Investor sentiment deteriorates as stock falls 23%

Is Procaps Group S.A. (NASDAQ:PROC) Worth US$3.7 Based On Its Intrinsic Value?

New major risk - Revenue and earnings growth

Hoche Partners Sends a Letter to Procaps Group

Hoche Partners Sends a Letter to Procaps Group

Investor sentiment improves as stock rises 16%

Third quarter 2023 earnings released: EPS: US$0.08 (vs US$0.22 in 3Q 2022)

Investor sentiment deteriorates as stock falls 19%

Procaps Group S.A. Announces Executive Changes, Effective January 15, 2024

Procaps Group S.A. Announces Executive Changes, Effective January 15, 2024

Investor sentiment deteriorates as stock falls 17%

Procaps Group S.A. to Report Q3, 2023 Results on Nov 14, 2023

New minor risk - Share price stability

Investor sentiment improves as stock rises 23%

Procaps Group S.A. Appoints Sandra Sanchez Y Oldenhage as A Director

Investor sentiment deteriorates as stock falls 19%

Second quarter 2023 earnings released: EPS: US$0.27 (vs US$0.068 loss in 2Q 2022)

Procaps Group S.A. to Report Q2, 2023 Results on Sep 05, 2023

Procaps Group S.A., Annual General Meeting, Jun 30, 2023

Procaps Group S.A. to Report Q1, 2023 Results on Jun 05, 2023

Consensus EPS estimates fall by 28%

Full year 2022 earnings released: EPS: US$0.42 (vs US$1.03 loss in FY 2021)

Investor sentiment improves as stock rises 18%

Investor sentiment improves as stock rises 15%

Now 21% undervalued after recent price drop

Investor sentiment improves as stock rises 15%

Less than half of directors are independent

Procaps Group S.A. Announces Board Changes

Procaps Group S.A. (NasdaqGM:PROC) announces an Equity Buyback for 2,000,000 shares, for $5 million.

Now 22% undervalued after recent price drop

Calculating The Intrinsic Value Of Procaps Group S.A. (NASDAQ:PROC)

Investor sentiment deteriorates as stock falls 16%

Procaps Group Announces Key Changes to the Board of Directors

Price target increased to US$13.00

Investor sentiment deteriorated over the past week

Third quarter 2022 earnings released

Procaps Group S.A. to Report Q3, 2022 Results on Nov 14, 2022

Now 22% undervalued after recent price drop

Now 23% undervalued after recent price drop

Second quarter 2022 earnings released: US$0.07 loss per share (vs US$0.01 loss in 2Q 2021)

Procaps Group reports Q2 results

Now 20% undervalued after recent price drop

First quarter 2022 earnings released: EPS: US$0.16 (vs US$0.18 loss in 1Q 2021)

Procaps Group S.A., Annual General Meeting, Jun 28, 2022

Procaps Group S.A. (NasdaqGM:PROC) entered into an agreenment to acquire Grupo Farmacéutico Somar, Sociedad Anónima Promotora de Inversión de Capital Variable from Advent International Corporation.

Procaps Group S.A. (NasdaqGM:PROC) entered into an agreenment to acquire Grupo Farmacéutico Somar, Sociedad Anónima Promotora de Inversión de Capital Variable from Advent International Corporation.

Forecast to breakeven in 2022

Now 20% undervalued after recent price drop

Forecast to breakeven in 2022

Procaps Group Announces Appointment of Melissa Angelini as Investor Relations Director

Procaps Group, S.A. (NasdaqGM:PROC) acquired 86,000 sq. ft. Pharmaceutical Production Facility Located in West Palm Beach, Florida from Strides Pharma Inc.

Calculating The Fair Value Of Procaps Group, S.A. (NASDAQ:PROC)

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin